Professor Andrew Jackson of Newcastle University is a leading researcher in neuroscience and neuroengineering, focusing on neural interfaces, optogenetics, and epilepsy. His work spans brain-computer interfaces, spinal cord stimulation, and sleep-dependent memory processes. Key research areas: closed-loop optogenetic systems, motor cortex dynamics, cerebellar-neocortical communication, and seizure pathway analysis. Collaborations with experts like Dr. Boubker Zaaimi, Professor Yujiang Wang, and Dr. Wei Xu. Develops implantable low-power platforms for real-time neural monitoring and stimulation. His recent publications highlight advancements in neuroprosthetics for motor recovery post-stroke/spinal injury, cortical chloride homeostasis in epilepsy, and mechanisms of brain self-regulation during movement and sleep. Technologies pioneered include flexible neural electrodes, temperature self-monitoring optoelectronics, and wearable bioelectrical signal systems. His work integrates computational neuroscience with clinical applications in motor disorders and epilepsy.
Professor Tim Denison FREng holds a joint appointment in the Department of Engineering Science and Nuffield Department of Clinical Neurosciences at the University of Oxford, where he serves as the Royal Academy of Engineering Chair in Emerging Technologies and an MRC Investigator. His research focuses on the fundamentals of physiologic closed-loop systems and developing next-generation neural interface technologies for treating chronic neurological diseases. Professor Denison received his A.B. in Physics from The University of Chicago, followed by M.S. and Ph.D. degrees in Electrical Engineering from MIT. He later completed an MBA at The University of Chicago, where he was named a Wallman Scholar. His research spans neural engineering, closed-loop neuromodulation systems, and computational neuroscience, with particular emphasis on deep brain stimulation, neural oscillations, and adaptive neurostimulation techniques. His work integrates engineering principles with clinical neuroscience to develop innovative treatments for neurological disorders. Professor Denison's approach combines computational modeling with experimental validation to optimize brain stimulation parameters for individual patients. Professor Denison has received numerous prestigious awards, including membership in the Bakken Society (2012, Medtronic's highest technical honor), the Wallin leadership award (2014), election to the College of Fellows for the American Institute of Medical and Biological Engineering (2015), and recognition as a Fellow of the Royal Academy of Engineering (FREng). As a former Technical Fellow at Medtronic PLC and Vice President of Research & Core Technology for the Restorative Therapies Group, Professor Denison brings significant industry experience to his academic work. His research group focuses on developing advanced neurostimulation technologies that incorporate chronobiology principles and adaptive algorithms to improve treatment outcomes for neurological conditions.
Peter A. Tass is a Professor of Neurosurgery at Stanford University's School of Medicine, where he leads the Tass Lab within the Department of Neurosurgery. His research focuses on developing groundbreaking neuromodulation techniques designed to impact the course of neurological diseases including Parkinson's disease, stroke, epilepsy, and tinnitus. The Tass Lab is part of several prestigious Stanford initiatives including Bio-X, the Wu Tsai Human Performance Alliance, the Maternal & Child Health Research Institute (MCHRI), and the Wu Tsai Neurosciences Institute. MD from Universities of Ulm and Heidelberg, Germany (1989) PhD in Physics from University of Stuttgart, Germany (1993) Diploma (master's degree) in Mathematics from University of Stuttgart, Germany (1993) Habilitation thesis in Physiology from RWTH Aachen University, Aachen, Germany (2001) Dr. Tass's primary research interests center around computational neuroscience approaches to understanding and treating neurological disorders. His lab pioneers neuromodulation techniques based on thorough computational modeling that employs dynamic self-organization, plasticity, and other neuromodulation principles to produce sustained therapeutic effects after stimulation. He specifically focuses on developing stimulation methods that cause sustained neural desynchronization by unlearning abnormal synaptic interactions. His work spans both invasive techniques like deep brain stimulation and non-invasive approaches such as vibrotactile and acoustic stimulation. Current projects involve developing novel therapies for Parkinson's disease, epilepsy, tinnitus, and other neurological conditions using comprehensive computational neuroscience methods derived from non-linear dynamics, statistical physics, and numerics. Analysis of Dr. Tass's recent publications reveals a strong focus on coordinated reset stimulation techniques, neural network modeling with plasticity mechanisms, and computational approaches to brain stimulation. His work consistently bridges theoretical computational neuroscience with clinical applications, particularly for Parkinson's disease treatment. A significant portion of his recent research examines how stimulation parameters, sequences, and timing affect long-lasting desynchronization effects in neural networks. His publications demonstrate an interdisciplinary approach combining physics, mathematics, neuroscience, and clinical medicine to develop novel therapeutic interventions. Member of the European Academy of Sciences and Arts (2012) Nicolaus August Otto Innovation Prize (2011) German Innovation Award in Medicine (2011) Rapid Response Innovation Awards from The Michael J. Fox Foundation (2009, 2010) Runner-up for the German future prize (2006) Erwin Schrödinger prize (2005) Fritz Winter prize (2000) Dr. Tass actively mentors a diverse team of researchers including staff scientists, postdoctoral fellows, clinician-scientists, and students. His lab currently includes researchers with backgrounds in physics, computational neuroscience, biomedical engineering, and clinical neurology. The lab is involved in multiple clinical trials, including studies on coordinated reset spinal cord stimulation and vibrotactile coordinated reset stimulation for Parkinson's disease. His research is supported by various funding sources including foundations focused on neurological disorders and innovation in medical technology. Dr. Tass collaborates extensively with both internal Stanford researchers and external collaborators worldwide. The Tass Lab at Stanford is a multidisciplinary research group comprising physicists, neuroscientists, engineers, and clinicians working together to develop novel neuromodulation therapies. The lab team includes staff scientists like Justus Kromer (theoretical physicist), postdocs like Daniel Ehrens and Kanishk Chauhan, clinician-scientists like Tina Munjal, and clinical research coordinators. The lab maintains active collaborations with Stanford colleagues across departments including Kwabena Boahen, Vivek P. Buch, and Jaimie Henderson, as well as external collaborators like Alexander Neiman and Kęstutis Pyragas. Current research directions include developing non-invasive vibrotactile treatments for Parkinson's disease, acoustic coordinated reset therapy for tinnitus, and responsive deep brain stimulation for conditions like loss-of-control eating.
Dr. Boubker Zaaimi is a Lecturer in Neuroscience at Aston University, affiliated with the School of Life & Health Sciences under the College of Health and Life Sciences. His 15+ years of experience focus on implanting electrodes in animal models (rodents to primates) to study brain activity modulation, particularly in stroke and epilepsy contexts. He specializes in brain-machine interfaces, optogenetics, and closed-loop protocols to regulate neural activity. Key projects include the CANDO project (Newcastle University) and collaborations with DARPA and industry partners like Autifony Therapeutics. His research uses magnetoencephalography (MEG) to advance human brain activity recording and modulation techniques. Employment History: Multiple postdoctoral roles at Newcastle University, Northwestern University, and City College, NY, culminating in his current faculty position. Research Interests: Optogenetic control, neural dynamics in primates, spinal cord plasticity, and neuromodulation therapies. His work bridges basic science and clinical applications, with recent focus on non-invasive neurostimulation (e.g., brain-responsive music) and closed-loop systems for epilepsy management. Over 19 peer-reviewed articles highlight his contributions to understanding neural pathways and developing therapeutic interventions.
Dr. Eric Meyers is an Assistant Professor in the Department of Bioengineering at the Erik Jonsson School of Engineering and Computer Science, University of Texas at Dallas. He holds a Ph.D. in Biomedical Engineering and dual Bachelor's/Master's degrees in Electrical Engineering from the same institution. His research focuses on closed-loop neurotechnology, neuromodulation, and bioelectronic medicine to enhance recovery from nervous system injuries. Key projects include developing wearable EMG sleeves for stroke rehabilitation and closed-loop neuromodulation systems to restore motor function. Education: B.S. (2012), M.S. (2018), Electrical Engineering; Ph.D. (2017), Biomedical Engineering – all from UTD His research interests span machine learning applications in neurorehabilitation, biomarker discovery for neurological conditions, and clinical translation of bioelectronic therapies. Recent work emphasizes wearable devices for real-time motor function assessment and neuromodulation-driven recovery strategies. Publications highlight advancements in EMG-based neural interfaces, closed-loop algorithms for stroke therapy, and innovative FES systems. His lab actively collaborates on projects funded by NIH and industry partnerships, with a focus on translating technologies to clinical settings.
Kelly Bijanki is an Associate Professor of Neurosurgery, Director of Intracranial Monitoring Research, and holds joint appointments in Psychiatry and Neuroscience at Baylor College of Medicine. Her work bridges clinical neurosurgery and neuroscience, focusing on understanding the neural basis of affective disorders and developing neuromodulation therapies. She directs the Translational Neuromodulation Lab, where she leverages stereotactic electroencephalography (sEEG) to study deep brain structures critical to emotional functioning. Dr. Bijanki's research explores the electrophysiological, neurobiological, and behavioral correlates of neuromodulation of affective neural circuits. Her lab primarily works with patients undergoing intracranial monitoring for epilepsy or depression, using this unique platform to conduct in-vivo studies of neural correlates to affective function. Her work has identified novel stimulation-based strategies for evoking positive affect and anxiolysis, including the discovery that stimulation to the cingulum bundle evokes changes in anxiolysis, mirth, and euphoria, which was featured as a cover article in the Journal of Clinical Investigation and highlighted in the NIH Director's Blog. Analysis of her recent publications reveals a consistent focus on mapping neural circuits involved in emotion processing, particularly using stereo-EEG informed deep brain stimulation approaches. Her work spans multiple psychiatric conditions including depression, obsessive-compulsive disorder, and anxiety disorders, with a strong emphasis on translating electrophysiological findings into therapeutic applications. The integration of computational approaches, particularly machine learning for decoding neural activity related to mood states, represents a growing trend in her research program. Her scientific achievements include: United States Patent (US:11,241,575) for a novel stimulation-based strategy for evoking positive affect and anxiolysis Journal of Clinical Investigation cover article (March 2019) on cingulum stimulation enhancing positive affect NIH Director's Blog feature highlighting her groundbreaking work Multiple NIH grants including R01, R21, and K01 awards Dr. Bijanki mentors a diverse team including graduate students, postdoctoral fellows, and undergraduate researchers. Her research program is generously funded by multiple NIH grants (R01-MH127006, R01-MH130597, K01MH116364, R21NS104953, UH3NS103549), as well as support from the ARCO Foundation, Caroline Wiess Law Fund, American Foundation for Suicide Prevention, and NARSAD. She maintains strong collaborations with researchers at institutions including UTSW, Iowa, Duke, UCLA, Brown, UPenn, and WashU. The Translational Neuromodulation Lab operates at the intersection of clinical neurosurgery, neuroscience, and engineering, utilizing stereo-EEG as a research platform to study deep brain structures involved in emotional processing. The lab employs multiple methodologies including advanced surgical neuroimaging, affective electrophysiology, autonomic surveillance, facial motor analysis, and pulse-evoked potentials to comprehensively characterize mood-relevant neural circuits. Their current flagship project involves using explainable artificial intelligence to map the relationship between mood and intracranial neural activity, with the goal of developing naturalistic patterns of intracranial stimulation for therapeutic applications.
Allon Guez is a Professor in the Department of Electrical and Computer Engineering at Drexel University. His research focuses on control systems, robotics, artificial intelligence, medical robotics, and automated decision making. He actively bridges academia and industry through high-tech entrepreneurship. Education PhD in Electrical Engineering, University of Florida MS in Electrical Engineering, University of Florida MBA in Finance, Drexel University BS in Electrical Engineering, Technion - Israel Institute of Technology His research portfolio spans medical robotics, automated decision making systems, and advanced control algorithms. Key areas include wearable safety devices, radiation control in imaging systems, and closed-loop brain stimulation technologies. Notable contributions include founding ControlRad (radiation reduction systems) and GraceFall (fall detection technology). His work demonstrates a strong emphasis on translating academic research into commercial medical devices. Recent publications highlight innovations in: Fetal brainwave monitoring Postural disturbance detection Seizure prediction algorithms Magnetic microrobotics Dynamic CT collimation Cardiac tissue modeling
Dr. Changsheng Wu is a Professor at the National University of Singapore (NUS), leading the Lab for Intelligent Sensing, Harvesting and Actuation (LISHA). He holds a Bachelor's from NUS and a PhD from Georgia Tech, with postdoctoral research at Northwestern University. His work focuses on wireless wearables, bioelectronics, energy harvesting, and advanced manufacturing for sustainable solutions. Education: Bachelor in Engineering Science (First Class Honours), NUS PhD in Materials Science and Engineering, Georgia Institute of Technology Postdoctoral Research, Querrey Simpson Institute for Bioelectronics, Northwestern University Research Interests: Wireless bioelectronics for clinical health monitoring Energy harvesting via nanogenerators Soft skin-electronics interfaces using metastructures Programmable materials for adaptive systems Advanced manufacturing techniques for wearable devices Key Achievements: Over 50 publications and 5 patents Recipient of TechConnect 2018 Innovation Award and 56th R&D 100 Award Developed wireless implantable sensors for tissue monitoring and bioresorbable medical devices Teaching: MLE5220: Finite Element Method in Materials MLE5238: Bioelectronics Laboratory: His LISHA lab pioneers innovations in self-powered systems, wearable health monitoring, and biohybrid robots. Current projects include metamaterial-based sensors and sustainable energy conversion materials.
Karim Oweiss is a Pre-eminent Professor at the University of Florida, with joint appointments in the Department of Biomedical Engineering (Herbert Wertheim College of Engineering), Electrical and Computer Engineering, and Neuroscience (McKnight Brain Institute). He holds a Ph.D. in Electrical Engineering and Computer Science from the University of Michigan (2002). His research focuses on neural mechanisms of sensorimotor integration and the development of clinically viable brain-machine interfaces (BMIs) to restore damaged neurological function. His work spans computational neuroscience, neural decoding, optogenetics, and advanced neurotechnology, with a strong emphasis on closed-loop systems and neural plasticity. 2025 : Chemogenetic stimulation of phrenic motor output and diaphragm activity 2024 : Chemogenetic phrenic motoneuron activation enables increased tidal volume 2023 : Compressive sensing of functional connectivity maps from patterned optogenetic stimulation Oweiss has received the NSF Excellence in Neural Engineering Award (2001) and is a Senior Member of the IEEE. He has published extensively on topics including neural decoding, compressive sensing, and multiscale neural interfacing. As editor of Statistical Signal Processing for Neuroscience and Neurotechnology (2010), he has contributed significantly to the field's methodological foundations. His lab develops tools like NeuroQuest for large-scale neural data analysis and implantable neuroprocessors for wireless BMI applications.
Dr. Enrico Opri is an Assistant Professor in the Department of Biomedical Engineering at the University of Michigan , where he directs the Opri Lab. His research focuses on engineering novel methodologies to automate and enhance clinical procedures in neuromodulation for neurological disorders such as Parkinson’s, Tourette syndrome, essential tremor, and epilepsy. Research Focus Neurophysiological activity in basal ganglia-thalamocortical circuits Therapeutic effects of neuromodulation (e.g., Deep Brain Stimulation, cortical stimulation mapping) Identification of neurological biomarkers for improved clinical procedures Advancements in closed-loop neurostimulation systems Article Trends Dr. Opri's recent publications emphasize closed-loop deep brain stimulation (DBS) systems, computational modeling of neural activity, and the identification of biomarkers for neurological disorders. Key subfields include Parkinson’s disease motor dynamics, Tourette syndrome tic detection, essential tremor treatment, and cortico-thalamic coupling mechanisms. His work bridges biomedical engineering and clinical neuroscience, focusing on translating technological innovations into therapeutic applications.
Surjo R. Soekadar is the Einstein Professor of Clinical Neurotechnology at Charité – University Medicine Berlin. He leads the Clinical Neurotechnology Laboratory , which focuses on developing noninvasive neurotechnologies for treating neurological and psychiatric disorders through closed-loop brain stimulation and advanced brain-machine interfaces (BCI/BMI). His work integrates real-time EEG/MEG monitoring with electromagnetic stimulation to modulate pathological brain oscillations and enhance neuroplasticity in conditions like stroke, spinal cord injury, and psychiatric disorders. Education : Studied medicine in Mainz, Heidelberg, and Baltimore Clinical Training : Residency in Psychiatry and Psychotherapy at University of Tübingen Academic Journey : 2008-2011 Research Fellow at NINDS (USA); 2017 Venia Legendi at University of Tübingen; 2018 First Professor of Clinical Neurotechnology in Germany His research interests span: • Closed-loop neurostimulation combining real-time brain state monitoring with targeted intervention • Next-generation BCI using optically pumped magnetometers (OPM) for mobile MEG recordings • Neurorehabilitation through exoskeleton control and sensory feedback • Neurophysiological modeling of entropy measures and phase flows Recent publications highlight: • Adaptive deep brain stimulation protocols • Real-time phase-sensitive tACS applications • OPM-based BCI innovations • Stroke recovery mechanisms through corticospinal tract analysis Scientific recognition includes: International BCI Research Award BIOMAG Award NARSAD Young Investigator Award Funded by the European Research Council (ERC) , his lab trains doctoral students like David Haslacher (EEG/MEG integration), Khaled Nasr (multicoil TMS optimization), and Annalisa Colucci (entropy-driven BCI development). The team also explores quantum AI applications in clinical decision-making and bidirectional BCI systems using OPM and tES.
Paul Nuyujukian serves as an Assistant Professor of Bioengineering and Neurosurgery, with courtesy appointment in Electrical Engineering at Stanford University. He is a Faculty Scholar of the Wu Tsai Neurosciences Institute, directing the Brain Interfacing Laboratory where his team develops neural interface technologies for clinical applications in stroke and epilepsy. Education: MD, Stanford University (2014) PhD in Bioengineering, Stanford University (2012) BS, UCLA (2006) Dr. Nuyujukian's research integrates motor systems neuroscience with neuroengineering to decode brain activity during movement and recovery from injury. His laboratory pioneers brain-machine interface (BMI) platforms that translate neural signals into communication and control systems, with particular emphasis on intracranial EEG recording and real-time neural decoding. Current work focuses on developing clinically viable BMI solutions for neurological conditions through both preclinical models and human trials, advancing our understanding of neural population dynamics in health and disease. Recent publications reveal strong trends in intracranial EEG acquisition systems, seizure detection algorithms using information theory, and closed-loop BMI applications for ambulatory neuroscience. His work bridges fundamental neuroscience with clinical translation, particularly in epilepsy monitoring, chronic pain management, and neural prosthetics for paralysis. A notable emphasis exists on creating scalable, minimally invasive recording platforms that reduce clinical burden while maintaining high-fidelity neural data. Scientific Awards: No specific awards listed in provided materials As director of the Brain Interfacing Laboratory, Dr. Nuyujukian mentors students and collaborators in neural engineering research while securing grant funding for BMI development. His group maintains active collaborations with Stanford's Department of Neurosurgery and Neurology for clinical translation, with current projects including real-time decision-state decoding and personalized network mapping for pain management. The laboratory operates advanced facilities for both animal and human neural recording, emphasizing seamless integration of engineering innovation with clinical neuroscience. The Brain Interfacing Laboratory comprises multidisciplinary scientists and engineers developing next-generation neural interfaces. Current initiatives include the LiCoRICE platform for ambulatory neuroscience, seizure detection systems using compression-enabled entropy estimation, and ketamine's effects on hippocampal connectivity. The team actively participates in clinical trials for BMI applications in stroke rehabilitation and epilepsy, with strong partnerships across Stanford's medical and engineering schools to accelerate technology translation.
Hayriye Cagnan is a Senior Lecturer (Associate Professor) in the Department of Bioengineering at Imperial College London’s Faculty of Engineering. She specializes in neural engineering and movement disorders, focusing on deep brain stimulation (DBS) and tremor pathophysiology. Her research integrates computational modeling, signal processing, and clinical neuroscience to develop adaptive neurotherapies. Cagnan holds a Ph.D. in Neuroscience from the University of Amsterdam and Philips Research, and has held postdoctoral positions at the University of Oxford and University College London. Education: B.Sc. in Electrical and Electronics Engineering (Cornell University, 2000–2004) – Fulbright Scholar M.Sc. in Engineering and Physical Science in Medicine (Imperial College London, 2004–2005) – Chevening Scholar Ph.D. in Neuroscience (University of Amsterdam/Philips Research, 2010) Research Interests: Her work addresses neural mechanisms underlying Parkinson’s disease, essential tremor, and other movement disorders. Key areas include: Development of adaptive DBS systems for tremor management Neural circuit dynamics and oscillations in basal ganglia networks Non-invasive neurostimulation techniques (e.g., TMS, tRNS) Machine learning for optimizing neurotherapeutic interventions Publications: Recent work emphasizes closed-loop systems, phase-specific stimulation, and translational neuroscience. Her studies explore how DBS modulates movement speed, reward processing, and neural oscillatory patterns in Parkinsonian patients. Awards: MRC Career Development Award (2018) MRC Skills Development Fellowship (2015) British Chevening Scholarship (2004) Lab & Collaboration: Leads the Neuroengineering and Dynamic Systems Lab at Imperial, collaborating with clinicians and engineers to advance neuromodulation therapies. Active in initiatives like NEUROMOD+ for next-generation neurotherapies.
Joline Fan, MD, MS is an Assistant Professor at the University of California, San Francisco (UCSF) in the Departments of Neurology (Division of Epilepsy) and Psychiatry & Behavioral Sciences. She is affiliated with the UCSF Weill Institute for Neurosciences, where she conducts cutting-edge research at the intersection of neurology, psychiatry, and neurotechnology. Dr. Fan completed her education at prestigious institutions: B.S.E. in Chemical and Biological Engineering from Princeton University, M.S. in Bioengineering from Stanford University, and M.D. from UCSF. She furthered her training with a Neurology Residency and Epilepsy Fellowship at UCSF, establishing her expertise in clinical neurology and epilepsy management. Her research program focuses on developing innovative neurostimulation technologies for neuropsychiatric disorders and exploring the complex relationship between sleep and epilepsy through multimodal neuroimaging. As an epileptologist, Dr. Fan specializes in invasive recording methods including intracranial responsive neurostimulation and stimulation mapping. She is pioneering personalized, non-invasive, low-intensity focused ultrasound methods for treating conditions like depression and epilepsy, bridging engineering approaches with clinical neuroscience. Analysis of Dr. Fan's recent publications reveals a strong focus on intracranial neurophysiology, brain network mapping, and closed-loop neuromodulation systems. Her work integrates multiple disciplines including neurology, psychiatry, neuroengineering, and data science to develop personalized treatments for treatment-resistant depression, obsessive-compulsive disorder, and epilepsy. The research demonstrates increasing translational impact with growing clinical applications of neuromodulation technologies. Dr. Fan has received significant recognition for her work: American Epilepsy Society (AES) 2022 Young Investigator Award University of California San Francisco 2024 Chen Scholar Award Dr. Fan actively mentors residents, fellows, and UCSF students on research projects. Her research is supported by multiple significant grants including a Brain & Behavior Research Foundation NARSAD Young Investigator Grant for 'Mapping Corticolimbic Circuitry of Arousal Using Intracranial Electrophysiology' (2023-2025), an NIH/NINDS K23 award for 'Network dynamics of sleep-wake states in epilepsy' (2023-2027), and previously a Doris Duke Charitable Foundation Physician Scientist Fellowship (2021-2023). Working within the UCSF Weill Institute for Neurosciences, Dr. Fan collaborates with multidisciplinary teams across neurology, psychiatry, neurosurgery, and engineering to advance understanding of brain circuitry and develop novel neuromodulation approaches for complex neuropsychiatric conditions.
Claudia Cea is an Assistant Professor in the Department of Electrical & Computer Engineering at Yale University's School of Engineering and Applied Science. Her research focuses on developing soft, multifunctional bioelectronic devices designed to interface with the nervous system for long-term neural interrogation and modulation. She leads The Cea Group, which integrates principles from bioelectronics, materials science, and neuroscience to engineer conformable, high-resolution neural interfaces. Ph.D., Columbia University M.Sc., San Diego State University B.Sc., University of Pisa Her research interests lie at the intersection of bioelectronics , neural engineering , and soft materials design , with a focus on creating minimally invasive tools for understanding brain–body communication. By combining electrical, optical, and chemical modalities, her lab develops technologies capable of both recording and modulating neural activity in central and peripheral circuits. These innovations aim to uncover fundamental neural mechanisms and translate them into therapies for neurological, psychiatric, and systemic disorders. The recent publications demonstrate a strong trajectory in implantable bioelectronics , particularly in organic electrochemical transistors , ionic communication systems , and multimodal neural interfaces . Her work consistently appears in top-tier journals such as Nature Materials , Science Advances , and PNAS , reflecting significant impact in neuroengineering and bioelectronic medicine. The research emphasizes device autonomy, biocompatibility, and real-time neural signal processing. Her scientific achievements have been recognized with prestigious honors: MIT Technology Review 35 Innovators under 35 SEAS Ph.D. Research Symposium Winner, Columbia University CSNE Hackathon Winner, University of Washington Shiley Scholarship in Bioengineering Claudia Cea has secured competitive funding and recognition that support her lab’s innovative work. While specific grant details are not listed, awards such as the Shiley Scholarship and hackathon wins indicate strong support from institutions like the Center for Sensorimotor Neural Engineering (CSNE). Her role as principal investigator of The Cea Group suggests active mentorship of graduate students and postdoctoral researchers in interdisciplinary research. The lab fosters collaboration across engineering, neuroscience, and clinical domains to accelerate translation. The Cea Group is dedicated to advancing soft, multifunctional electronics for biomedical applications. The team focuses on designing conformable, implantable devices that seamlessly integrate with biological tissues. Their work spans materials synthesis, device fabrication, in vivo testing, and clinical translation, aiming to bridge gaps between engineering innovation and medical need. The lab environment promotes creativity, rigor, and translational thinking in next-generation neural technologies.
